Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Wibi Works LLC (AKA: Wibi+Works LLC)
Profile last edited on: 12/29/22      CAGE: 645M7      UEI: DQ3MGB1GVMP8

Business Identifier: Stem cell technology and therapies based on mesenchymal stem cells to treat arthritis
Year Founded
2010
First Award
2012
Latest Award
2013
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

3210 Merryfield Row
San Diego, CA 92121
   (858) 242-1519
   N/A
   www.wibiworks.com
Location: Multiple
Congr. District: 52
County: San Diego

Public Profile

Wibi+Works LLC is an emerging biotechnical company located in the Janssen Labs incubator space in San Diego, California. ​Wibi+Works has assembled a team to quickly advance a unique patent-pending technology for safe and effective cell therapies that target hard to treat inflammatory diseases. Wibi+Works is developing mesenchymal stem cell (MSC) based treatements to target immune unresponsive disease and inflammatory diseases. ​

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$352,102
Phase II Dollars
$47,898
Total Awarded
$400,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2013 2 NIH $400,000
Project Title: The First Locally Acting Anti-Inflammatory Stem Cell-Based Therapy For Rheumatoid

Key People / Management

  Ruth S Waterman -- CEO and Medical Director

  Aline M Betancourt -- Founder and CSO

Company News

There are no news available.